Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study.
about
Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study.Systematic review and network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis.Editorial: do thiopurines and biologics decrease the risk of colectomy?Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
P2860
Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comparison of Infliximab and A ...... ationwide Danish Cohort Study.
@en
type
label
Comparison of Infliximab and A ...... ationwide Danish Cohort Study.
@en
prefLabel
Comparison of Infliximab and A ...... ationwide Danish Cohort Study.
@en
P2093
P2860
P1476
Comparison of Infliximab and A ...... ationwide Danish Cohort Study.
@en
P2093
Mikael Andersson
Nynne Nyboe Andersen
Siddharth Singh
P2860
P304
1218-1225.e7
P356
10.1016/J.CGH.2016.11.024
P407
P577
2016-11-29T00:00:00Z